Medical device quality is no longer just about documentation, audits, and compliance checklists. As devices become more connected, software-driven, and globally distributed, manufacturers need a smarter way to anticipate, control, and respond to risk across the entire product lifecycle.
This white paper explores how ISO 14971 can be embedded as a lifecycle operating model connecting design controls, clinical evidence, supplier quality, production risk, post-market surveillance, and CAPA into one cohesive risk-based quality system.
Download the white paper to learn how medical device organizations can move from static risk documentation to a connected, audit-ready quality model that supports patient safety, regulatory confidence, and faster market readiness.
Inside the white paper, you’ll discover:
- Why compliance-based quality is no longer enough
- How ISO 14971 supports lifecycle risk governance
- How CAPA and post-market data can close the risk loop
- How ISO 13485, FDA QMSR, and EU MDR align around risk-based quality
- How Freyr helps manufacturers build integrated, inspection-ready quality systems
Build a stronger, more proactive quality strategy.
Fill the form below to download the White Paper
